Jukka Hartikka is an experienced medical writer and scientist with over 20 years of industry background in biotechnology and pharmaceutical companies. His areas of expertise include oncology, vaccines, and neurobiology with a focus on breast cancer, melanoma, CMV, influenza, and HSV-2. Hartikka has supported global regulatory submissions, and he is familiar with StartingPoint templates, FDA/ICH guidance documents, eCTD structure, and electronic document management systems. He holds a Ph.D. in Biochemistry from the University of Basel, and he has conducted research on neurobiology and molecular biology at the University of Miami. Throughout his career, he has held various positions in different organizations such as Kite Pharma, Puma Biotechnology, Inc., Vical, and Preclinical Research, Sandoz Ltd. Hartikka's extensive knowledge and skills make him an invaluable asset to any organization seeking regulatory or scientific medical writing support.